Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Jubilant Pharmova Gains 11%; BSE HEALTHCARE Index Up 0.1%
Fri, 13 Sep 13:47

Jubilant Pharmova Gains 11%; BSE HEALTHCARE Index Up 0.1%Image source: Kameleon007 /www.istockphoto.com

Jubilant Pharmova share price has zoomed 11% and is presently trading at Rs 1,144.2.

Meanwhile, the BSE HEALTHCARE index is at 44,324.9 (up 0.1%).

Among the top gainers in the BSE HEALTHCARE index today are J.B.Chemicals (up 2.3%) and FORTIS HEALTHCARE (up 1.8%).

KIMS (down 79.7%) and NARAYANA HRUDAYALAYA (down 4.4%) are among the top losers today.

Over the last one year, Jubilant Pharmova has moved up from Rs 450.3 to Rs 1,144.2, registering a gain of Rs 693.9 (up 154.1%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,436.8 to 44,324.9, registering a gain of 55.9% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 154.1%), SUVEN PHARMACEUTICALS (up 131.3%) and Glenmark Pharma (up 115.5%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 82,873.5 (down 0.1%).

The top losers among the BSE Sensex today are ITC (down 1.4%) and MUNDRA PORT & SEZ (down 1.2%). The most traded stocks in the BSE Sensex are Tata Steel and NTPC.

In the meantime, NSE Nifty is at 25,364.8 (down 0.1%). SBI LIFE INSURANCE and HDFC LIFE INSURANCE are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 67,127.1 to 82,873.5, registering a gain of 15,746.4 points (up 23.5%).

Jubilant Pharmova Financial Update...

Jubilant Pharmova net profit grew 6410.8% YoY to Rs 4,818 million for the quarter ended June 2024, compared to a profit of Rs 74 million a year ago. Net sales rose 9.1% to Rs 17,317 million during the period as against Rs 15,869 million in April-June 2023.

For the year ended March 2024, Jubilant Pharmova reported 212.0% increase in net profit to Rs 727 million compared to net loss of Rs 649 million during FY23. Revenue of the company grew 6.7% to Rs 67,029 million during FY24.

The current Price to earnings ratio of Jubilant Pharmova, based on rolling 12 month earnings, stands at 34.8.


Equitymaster requests your view! Post a comment on "Jubilant Pharmova Gains 11%; BSE HEALTHCARE Index Up 0.1%". Click here!